<code id='6C57D9C556'></code><style id='6C57D9C556'></style>
      • <acronym id='6C57D9C556'></acronym>
      <center id='6C57D9C556'><center id='6C57D9C556'><tfoot id='6C57D9C556'></tfoot></center><abbr id='6C57D9C556'><dir id='6C57D9C556'><tfoot id='6C57D9C556'></tfoot><noframes id='6C57D9C556'>
      • <optgroup id='6C57D9C556'><strike id='6C57D9C556'><sup id='6C57D9C556'></sup></strike><code id='6C57D9C556'></code></optgroup>
        5. <b id='6C57D9C556'><label id='6C57D9C556'><select id='6C57D9C556'><dt id='6C57D9C556'><span id='6C57D9C556'></span></dt></select></label></b><u id='6C57D9C556'></u>
          <i id='6C57D9C556'><strike id='6C57D9C556'><tt id='6C57D9C556'><pre id='6C57D9C556'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / entertainment / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-09-30 10:35:50 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：fashion   
                                        
                                      
                                      Page View：4
                                  
                                    
          
                                   
          Franklin faces
          Adobe
          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.
          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.
          advertisement
          Arch declined to comment on the new fundraising.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Doctors in states that ban abortion can still help patients
                                
                            
          Next article：  
                                      
                                          The cancer drug shortage isn’t new — and neither are the solutions
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles